beta

ALT

Altimmune, Inc.

Alt

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company, which is focused on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. Its portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Market Cap: 26.4 Million

Primary Exchange: NASDAQ

Website: http://www.altimmune.com

Shares Outstanding: 15.3 Million

Float: 12.7 Million

Dividend: (%)

Beta: 0.747212055978541

Sector: Commercial Services

Industry: Miscellaneous Commercial Services

Ethical Flags

Animal testing

Longest drawdown: 743 trading days

From: 2017-01-10 To: 2019-12-13

Lowest Point:

Altimmune appoints Will Brown as CFO.

via: SeekingAlpha at 2019-06-12 07:15:24:000

Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...

Altimmune appoints Will Brown as CFO.

via: SeekingAlpha at 2019-06-12 07:15:24:000

Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-05-05 10.0 1.0 10.0
Data provided by IEX Cloud